• DOI:10.1093/jac/dkw450
Corpus ID: 205153070

Linezolid: a promising option in the treatment of Gram-positives

@article{Bialvaei2017LinezolidAP,
  title={Linezolid: a promising option in the treatment of Gram-positives},
  author={A. Zahedi Bialvaei and M. Rahbar and M. Yousefi and Mohammad Asgharzadeh and Hossein Samadi Kafil},
  journal={Journal of Antimicrobial Chemotherapy},
  year={2017},
  volume={72},
  pages={354–364}
}

A. Zahedi Bialvaei, M. Rahbar, +2 authors Hossein Samadi Kafil

Published 2017

Medicine

Journal of Antimicrobial Chemotherapy

Linezolid, an oxazolidinone antimicrobial agent that acts by inhibiting protein synthesis in a unique fashion, is used in the treatment of community-acquired pneumonia, skin and soft-tissue infections and other infections caused by Gram-positive bacteria including VRE and methicillin-resistant staphylococci. Currently, linezolid resistance among these pathogens remains low, commonly <1.0%, although the prevalence of antibiotic resistance is increasing in many countries. Therefore, the… CONTINUE READING

View on Wolters Kluwer

academic.oup.com

Save to Library

Create Alert

Cite

Launch Research Feed